{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T09:24:31Z","timestamp":1774085071013,"version":"3.50.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"2-3","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1023\/a:1005944622003","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T00:10:48Z","timestamp":1040515848000},"page":"219-223","source":"Crossref","is-referenced-by-count":36,"title":["New cytotoxic drugs for intrathecal administration"],"prefix":"10.1007","volume":"38","author":[{"given":"Susan M.","family":"Blaney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David G.","family":"Poplack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"159847_CR1","first-page":"520","volume":"40","author":"C McCully","year":"1990","unstructured":"McCully C, Balis F, Bacher J et al.: A Rhesus monkey model for continuous infusion of drugs into cerebrospinal fluid. Lab Anim Sci 40: 520\u2013525, 1990","journal-title":"Lab Anim Sci"},{"key":"159847_CR2","first-page":"113","volume":"11","author":"S Blaney","year":"1992","unstructured":"Blaney S, Balis F, Murphy R et al.: A phase I study of intrathecal mafosfamide in patients with refractory meningeal malignancies. Proc Am Soc Clin Oncol 11: 113, 1992","journal-title":"Proc Am Soc Clin Oncol"},{"key":"159847_CR3","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/clpt.1982.90","volume":"31","author":"N Bachur","year":"1982","unstructured":"Bachur N, Collins J, Kelley J et al.: Diaziquone, 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone, plasma, and cerebrospinal fluid kinetics. Clin Pharmacol Ther 31: 650\u2013655, 1982","journal-title":"Clin Pharmacol Ther"},{"key":"159847_CR4","first-page":"6102","volume":"43","author":"G Curt","year":"1983","unstructured":"Curt G, Kelley J, Kufta C et al.: Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas. Cancer Res 43: 6102\u20136105, 1983","journal-title":"Cancer Res"},{"key":"159847_CR5","first-page":"1698","volume":"44","author":"S Zimm","year":"1984","unstructured":"Zimm S, Collins J, Curt G et al.: Cerebrospinal fluid pharmacokinetics of intraventricular and intravenous aziridinylbenzoquinone. Cancer Res 44: 1698\u20131701, 1984","journal-title":"Cancer Res"},{"key":"159847_CR6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1200\/JCO.1992.10.1.143","volume":"10","author":"S Berg","year":"1992","unstructured":"Berg S, Balis F, Zimm S et al.: Phase I\/II trial and pharmacokinetics of intrathecal diaziquone in refractory meningeal malignancies. J Clin Oncol 10: 143\u2013148, 1992","journal-title":"J Clin Oncol"},{"key":"159847_CR7","first-page":"992","volume":"45","author":"M Egorin","year":"1985","unstructured":"Egorin M, Fox B, Spiegel J et al.: Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182896). Cancer Res 45: 992\u2013999, 1985","journal-title":"Cancer Res"},{"key":"159847_CR8","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/0731-7085(90)80122-6","volume":"8","author":"J Beijnen","year":"1990","unstructured":"Beijnen J, Smith B, Keijer W et al.: High-performance liquid chromatographic analysis of the new antitumor drug DK&F 104864-A (NSC 609699) in plasma. J Pharm Biomed Anal 8: 789\u2013794, 1990","journal-title":"J Pharm Biomed Anal"},{"key":"159847_CR9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/jm00123a038","volume":"32","author":"R Hertzberg","year":"1989","unstructured":"Hertzberg R, Caranfa M, Holden K et al.: Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J Med Chem 32: 715\u2013717, 1989","journal-title":"J Med Chem"},{"key":"159847_CR10","first-page":"725","volume":"53","author":"S Blaney","year":"1993","unstructured":"Blaney S, Cole D, Balis F et al.: Plasma and cerebrospinal fluid pharmacokinetic study of topotecan in nonhuman primates. Cancer Res 53: 725\u2013727, 1993","journal-title":"Cancer Res"},{"key":"159847_CR11","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF00689195","volume":"36","author":"S Blaney","year":"1995","unstructured":"Blaney S, Cole D, Godwin D et al.: Intrathecal administration of topotecan in nonhuman primates. Cancer Chemother Pharmacol 36: 121\u2013124, 1995","journal-title":"Cancer Chemother Pharmacol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005944622003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005944622003\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005944622003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:09:09Z","timestamp":1749632949000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005944622003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":11,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["159847"],"URL":"https:\/\/doi.org\/10.1023\/a:1005944622003","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}